The data elements in the Data Table 4 report generated from CTRP closely align with that of the P30 Cancer Center Support Grant (CCSG). For information on the CCSG Data Table 4 report, refer to https://cancercenters.cancer.gov/GrantsFunding/eData. The following tables describe the data elements displayed in the CTRP Data Table 4 report, and demonstrate this alignment of data elements with the CCSG report. (For element descriptions, also refer to CTRP Dictionary.)
The following table describes the elements that appear in the CTRP report header, indicating the contents of the report. For instructions on configuring the report, refer to Generating the CTRP Data Table 4 Report.
CTRP Data Element | Description of CTRP Data Element | CCSG Column Name |
Cancer Center | The name of the CTRP organization family. The CTRP Data Table 4 report uses the CTRP Family-Organization relationships to select trials for a report. Reports are based on a Cancer Center Family. All trials for which the Family organizations or affiliates are participating sites are included in the report. The report includes only organization affiliations with effective dates (the Relationship End Date is null). | (No column) |
| Reporting Period Start Date | The date you have specified as the start date for the reporting period. | ReportingStartDate |
| Reporting Period End Date | The date you have specified as the end date for the reporting period. | ReportingEndDate |
| Trial Type Indicator | An indication whether the report includes data from a specific trial type or all trial types. For information, refer to Trial Types and Subtypes. | (No column) |
| Fiscal Year | The annual period you have specified for the report. It can be from October 1 of the prior year through September 30 of the year being described (such as fiscal year 2014). | FY |
The following table describes the elements that appear in the CTRP report as columns.
CTRP Data Element | Description of CTRP Data Element | CCSG Column Name |
P30 Grant Number | The Cancer Center Support Grant number. This is the P30 Grant Serial number (such as CAxxxxxx). This is NOT the grant associated with the lead organization of the trial. | GrantNumber |
Clinical Research Cat | The Clinical Research Category or trial type. The primary investigative techniques used in the protocol (interventional or non-interventional). The non-interventional category includes observational and ancillary/correlative studies. For information, refer to Trial Types and Subtypes. The report uses the following abbreviations:
| ClinicalResearchCat |
Study Source | The type of Data Table 4 funding sponsorship (National, Externally Peer-Reviewed, Institutional, or Industrial). For information, refer to CTRP Trial Categories (Study Sources). The report uses the following abbreviations:
Trials that are imported as Industrial/Other such as Consortia trials are included in the source category as N, E, I. The Study Source column indicates only the content of the trial, not how the trial is entered. | StudySource |
Specific Funding Source | The CTRP organizations listed as Data Table 4 Funding Sponsor for the trial. Sponsor or source of the funding mechanism. | FundingSource |
Primary Site | The The Data Table 4 Anatomic Sites for the trial. The anatomic site(s) on which the trial or study is focused. If a Clinical Research Study covers more than one Anatomic Site, the Site column should be coded “multiple.” For a list of values, refer to Data Table 4 Anatomic Site Values. | PrimarySite |
| NCT ID | The unique ID assigned to the trial by the National Clinical Trial program (ClinicalTrials.gov) for trials that have been submitted to ClinicalTrials.gov Protocol Registration System (PRS) previously. This ClinicalTrials.gov ID appears as "NCT" followed by 8 numeric characters (such as NCT12345678). | NCTID |
| NCI ID | The unique ID assigned to the trial by the CTRP. | NCIID |
Protocol ID | The lead organization trial ID. The unique ID assigned to the trial by the sponsoring organization, usually an accession number or a variation of a grant number. Multiple studies conducted under the same grant must each have a unique number. | ProtocolID |
| Other Protocol IDs | Additional IDs assigned to the trial, including the following:
| OthProtocolID |
| Local Trial ID | The unique ID assigned at the Cancer Center level and used at the sites level to identify a trial. | LocalTrialID |
Is Multi Institutional? | An indication whether there is more than one Cancer Center participating in the trial, derived as follows:
| IsMultiInst |
PI (Principal Investigator) - Last Name, First Name, MI | The Unable to render {include} The included page could not be found. The report displays the last name, first name, and middle initial of the PI for the trial or participating site, as follows:
| LastName, FirstName, MiddleName |
Prog Code | The program code, as an alphanumeric code that identifies the clinical research program. A code assigned by the Cancer Center to each participating site on a trial to classify the type of cancer research being conducted by the trial at that site. Multiple program codes are separated with semicolons. For instructions on specifying this information in CTRP, refer to Managing Program Codes. | ProgCode |
Open Date | The date on which the trial status became open to accrual. When you generate the report, the system considers:
For details, refer to Types of Trials Included in the CTRP Data Table 4 Report. | OpenDate |
Close Date | The date on which the trial status became any of the following statuses:
When you generate the report, the system considers:
For details, refer to Types of Trials Included in the CTRP Data Table 4 Report. | CloseDate |
Phase | The phase of investigation, as defined by the US FDA for trials involving investigational new drugs. For details, refer to Trial Phase Value Definitions. | Phase |
| Pilot | An indication whether the trial is a pilot trial. | IsPilot |
Primary Purpose | The main reason for conducting the trial. The report uses the following abbreviations:
For more information about these values, refer to Primary Purpose Value Definitions. For instructions on specifying the primary purpose for a trial, refer to Recording Trial Details. | PrimaryPurpose |
Official Title | The official name of the protocol provided by the study principal investigator or sponsor (as it appears in the protocol document). | OfficialTitle |
| Entire Study | The anticipated (target) number of subjects (accrual) for the entire trial if the specified Cancer Center is the lead organization. A blank field indicates that the specified Cancer Center is not the lead organization. | EntireStudy |
| Your Center Total | The participating site (Cancer Center) target accrual. The system displays this value if available in CTRP for the trial. For instructions on specifying this information in CTRP, refer to Managing Targeted Accrual. However, the value should be reported in this column if it is at all available, whether in CTRP or otherwise. | YourCenterTotal |
| Center Reporting Period | The total number of subjects accrued for the trial for all organizations in the Cancer Center Family with the relationship “Organization” for the time period you selected.
The system calculates accrual for a selected time period based on the difference between the last summary accrual reported before the time period and the last summary accrual reported within the time period. If no summary accrual was reported before the time period selected, the system displays the last summary accrual reported within the time period as the accrual count for the time period. For an example, refer to CTRP Data Table 4 Report Accrual Calculation. | Center12Mos |
| Center to Date | The total number of subjects accrued to date (as of the selected time period end date) for the trial for all organizations in the Cancer Center Family with the relationship “Organization”. For an example, refer to CTRP Data Table 4 Report Accrual Calculation. | CenterToDate |
| Other Reporting Period | The total number of subjects accrued for the trial for all organizations in the Cancer Center Family with the relationship “Affiliation” for the time period you selected.
The system calculates accrual for a selected time period based on the difference between the last summary accrual reported before the time period and the last summary accrual reported within the time period. If no summary accrual was reported before the time period selected, the system displays the last summary accrual reported within the time period as the accrual count for the time period. | Other12Mos |
| Other to Date | The total number of subjects accrued to date (as of the selected time period end date) for the trial for all organizations in the Cancer Center Family with the relationship “Affiliation”. | OtherToDate |
| Comments | In the CTRP reporting application, this column is intentionally blank. To use this column:
| Comments |
